Abstract
Our clinical experiences of AICD was reported. There were 4 patients of VT and 2 patients of VF with basic diseases such as myocardial infarction in 2 patients, left ventricular aneurysm in 1, aortic regurgitation in 1 and primary electrical disease in 2, all of whom were sudden cardiac death survivors. Antiarrhythmic drug resistance was confirmed in all of the VT patients, but it was undecided in VF patients because tachyarrhythmias were not inducible. Spontaneous discharge for VT occured in only one patient. Postoperative complications were necrosis of the skin, fracture of the electrode, pleuritis, spontaneous inactivation of the generator, one patients each, and incorrect discharge 2 patients. Although there was no operative death, two patients died of cerebrovascular accident 26 and 40 months postoperatively. One patients was reoperated due to device exhaustion and fracture of electrode. AICD was easily implantable and considered to be effective for the treatment of life threatening ventricular tachyarrhythmias.
